The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Open accessAbstract
Human papillomavirus (HPV)-induced cervical cancer is a major health issue among women from the poorly/under-developed sectors of the world. It accounts for a high-mortality rate because of its late diagnosis and poor prognosis. Initial establishment and subsequent progression of this form of cancer are completely dependent on two major oncogenes E6 and E7, which are expressed constitutively leading to tumorigenesis. Thus, manipulation of these genes represents the most successful form of cervical cancer therapy. In the present article, information on structural, functional, and clinical dimensions of E6 and E7 activity has been reviewed. The genome organization and protein structure of E6 and E7 have been discussed followed by their mechanism to establish the six major cancer hallmarks in cervical tissues for tumor propagation. The later section of this review article deals with the different modes of therapeutics, which functions by deregulating E6 and E7 activity. Since E6 and E7 are the biomarkers of a cervical cancer cell and are the ones driving the cancer progression, therapeutic approaches targeting E6 and E7 have been proved to be highly efficient in terms of focused removal of abnormally propagating malignant cells. Therapeutics including different forms of vaccines to advanced genome editing techniques, which suppress E6 and E7 activity, have been found to successfully bring down the population of cervical cancer cells infected with HPV. T-cell mediated immunotherapy is another upcoming successful form of treatment to eradicate HPV-infected tumorigenic cells. Additionally, therapeutics using natural compounds from plants or other natural repositories, i.e., phytotherapeutic approaches have also been reviewed here, which prove their anticancer potential through E6 and E7 inhibitory effects. Thus, E6 and E7 repression through any of these methods is a significant approach toward cervical cancer therapy, described in details in this review along with an insight into the signaling pathways and molecular mechanistic of E6 and E7 action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
An updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,480
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.
Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1156 · Cited by 1,889
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Bernard, H.-U., Burk, R. D., Chen, Z., van Doorslaer, K., Hausen, H. Z., & de Villiers, E.-M. (2010) · Virology · doi:10.1016/j.virol.2010.02.002 · Cited by 1,669
Integrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
Wright, A. V., Nuñez, J. K., & Doudna, J. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.035 · Cited by 989
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
DNA Double-Strand Break Repair: All's Well that Ends Well
Wyman, C., & Kanaar, R. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090451 · Cited by 803
The head and neck cancer immune landscape and its immunotherapeutic implications
Mandal, R., Şenbabaoğlu, Y., Desrichard, A., Havel, J. J., Dalin, M. G., Riaz, N., Lee, K.-W., Ganly, I., Hakimi, A. A., Chan, T. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89829 · Cited by 765
Bretones, G., Delgado, M. D., & León, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.013 · Cited by 747
Trimble, C. L., Morrow, M. P., Kraynyak, K. A., Shen, X., Dallas, M., Yan, J., Edwards, L., Parker, R. L., Denny, L., Giffear, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00239-1 · Cited by 727
Stevanović, S., Draper, L. M., Langhan, M. M., Campbell, T. E., Kwong, M. L., Wunderlich, J. R., Dudley, M. E., Yang, J. C., Sherry, R. M., Kammula, U. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.9093 · Cited by 682
Epidemiology and burden of HPV-related disease
Serrano, B., Brotons, M., Bosch, F. X., & Bruni, L. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.006 · Cited by 560
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Sadasivam, S., & DeCaprio, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3556 · Cited by 524
Phelps, W. C., Yee, C. L., Münger, K., & Howley, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90570-3 · Cited by 509
Egawa, N., & Doorbar, J. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.017 · Cited by 330
Barbosa, M. S., Edmonds, C., Fisher, C., Schiller, J. T., Lowy, D. R., & Vousden, K. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08091.x · Cited by 327
Papillomavirus E5: the smallest oncoprotein with many functions
Venuti, A., Paolini, F., Nasir, L., Corteggio, A., Roperto, S., Campo, M. S., & Borzacchiello, G. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-140 · Cited by 296
p53 Family and Cellular Stress Responses in Cancer
Pflaum, J., Schlosser, S., & Müller, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 291
Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses
Bagarazzi, M. L., Yan, J., Morrow, M. P., Shen, X., Parker, R. L., Lee, J. C., Giffear, M., Pankhong, P., Khan, A. S., Broderick, K. E., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004414 · Cited by 282
Gewin, L., Myers, H., Kiyono, T., & Galloway, D. A. (2004) · Genes & Development · doi:10.1101/gad.1214704 · Cited by 277
Kennedy, E. M., Kornepati, A. V. R., Goldstein, M., Bogerd, H. P., Poling, B. C., Whisnant, A. W., Kastan, M. B., & Cullen, B. R. (2014) · Journal of Virology · doi:10.1128/jvi.01879-14 · Cited by 262
Divya, C. S., & Pillai, M. R. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20170 · Cited by 248
Munagala, R., Kausar, H., Munjal, C., & Gupta, R. C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr192 · Cited by 236
Therapeutic vaccines for high-risk HPV-associated diseases
Chabeda, A., Yanez, R. J. R., Lamprecht, R., Meyers, A. E., Rybicki, E. P., & Hitzeroth, I. I. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2017.12.006 · Cited by 218
Veldman, T., Liu, X., Yuan, H., & Schlegel, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1435900100 · Cited by 214
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Thomas, M., Laura, R., Hepner, K., Guccione, E., Sawyers, C., Lasky, L., & Banks, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205668 · Cited by 204
White, E. A., Sowa, M. E., Tan, M. J. A., Jeudy, S., Hayes, S. D., Santha, S., Münger, K., Harper, J. W., & Howley, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116776109 · Cited by 198
White, E. A., Kramer, R. E., Tan, M. J. A., Hayes, S. D., Harper, J. W., & Howley, P. M. (2012) · Journal of Virology · doi:10.1128/jvi.02172-12 · Cited by 198
Spangle, J. M., & Münger, K. (2010) · Journal of Virology · doi:10.1128/jvi.00974-10 · Cited by 189
Mahata, S., Bharti, A. C., Shukla, S., Tyagi, A., Husain, S. A., & Das, B. C. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-39 · Cited by 187
Filippova, M., Song, H., Connolly, J. L., Dermody, T. S., & Duerksen-Hughes, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200113200 · Cited by 186
López-Ocejo, O., Viloria-Petit, A., Bequet-Romero, M., Mukhopadhyay, D., Rak, J., & Kerbel, R. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203817 · Cited by 183
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
Draper, L. M., Kwong, M. L. M., Gros, A., Stevanović, S., Tran, E., Kerkar, S., Raffeld, M., Rosenberg, S. A., & Hinrichs, C. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3341 · Cited by 183
Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery
LaVigne, A. W., Triedman, S. A., Randall, T. C., Trimble, E. L., & Viswanathan, A. N. (2017) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.08.004 · Cited by 181
HPV E6 protein interacts physically and functionally with the cellular telomerase complex
Liu, X., Dakic, A., Zhang, Y., Dai, Y., Chen, R., & Schlegel, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906357106 · Cited by 179
Nominé, Y., Masson, M., Charbonnier, S., Zanier, K., Ristriani, T., Deryckère, F., Sibler, A.-P., Desplancq, D., Atkinson, R. A., Weiss, E., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.024 · Cited by 177
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model
Jin, B. Y., Campbell, T. E., Draper, L. M., Stevanović, S., Weissbrich, B., Yu, Z., Restifo, N. P., Rosenberg, S. A., Trimble, C. L., & Hinrichs, C. S. (2018) · JCI Insight · doi:10.1172/jci.insight.99488 · Cited by 168
Khan, S. H., & Wahl, G. M. (1998) · PubMed · Cited by 166
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 166
Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines
McLaughlin-Drubin, M. E., Park, D., & Munger, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310432110 · Cited by 163
Human Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
Thomas, J. T., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1131-1137.1998 · Cited by 162
Kim, S. H., Juhnn, Y. S., Kang, S. B., Park, S. W., Sung, M. W., Bang, Y., & Song, Y. S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5561-x · Cited by 158
Zhang, B., Chen, W., & Roman, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510012103 · Cited by 156
Qu, X., Wang, P., Ding, D., Li, L., Wang, H., Ma, L., Zhou, X., Liu, S., Lin, S., Wang, X., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt571 · Cited by 155
McMurray, H. R., & McCance, D. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9852-9861.2003 · Cited by 143
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Hu, Z., Ding, W., Zhu, D., Yu, L., Jiang, X., Wang, X., Zhang, C., Wang, L., Ji, T., Liu, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci78206 · Cited by 132
Chakrabarti, O., Veeraraghavalu, K., Tergaonkar, V., Liu, Y., Androphy, E. J., Stanley, M., & Krishna, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5934-5945.2004 · Cited by 129
Current state in the development of candidate therapeutic HPV vaccines
Yang, A. D., Jeang, J., Cheng, Y.-Y., Cheng, T., Yang, B. K., Wu, T. ‐., & Hung, C. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1157477 · Cited by 127
Sima, N., Wang, W., Kong, D., Deng, D., Xu, Q., Zhou, J., Xu, G., Li, M., Lu, Y., Wang, S., et al. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0163-8 · Cited by 126
Zanier, K., ould M'hamed ould Sidi, A., Boulade-Ladame, C., Rybin, V., Chappelle, A., Atkinson, A., Kieffer, B., & Travé, G. (2012) · Structure · doi:10.1016/j.str.2012.02.001 · Cited by 125
McIntyre, M. C., Frattini, M. G., Grossman, S. R., & Laimins, L. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3142-3150.1993 · Cited by 121
Toussaint-Smith, E., Donner, D. B., & Roman, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207442 · Cited by 119
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7
Ohlenschläger, O., Seiboth, T., Zengerling, H., Briese, L., Marchanka, A., Ramachandran, R., Baum, M., Korbas, M., Meyer‐Klaucke, W., Dürst, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209584 · Cited by 117
CRISPR/Cas9‑mediated cervical cancer treatment targeting human papillomavirus E6
Yoshiba, T., Saga, Y., Urabe, M., Uchibor, R., Matsubara, S., Fujiwara, H., & Mizukami, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9815 · Cited by 115
MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors
Peter, M., Rosty, C., Couturier, J., Radvanyi, F., Teshima, H., & Sastre-Garau, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209625 · Cited by 114
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins
Garnett, T. O., & Duerksen-Hughes, P. J. (2006) · Archives of Virology · doi:10.1007/s00705-006-0821-0 · Cited by 114
Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells
Beer‐Romero, P., Glass, S., & Rolfe, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200872 · Cited by 114
New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
Yamato, K., Yamada, T., Kizaki, M., Ui-Tei, K., Natori, Y., Fujino, M., Nishihara, T., Ikeda, Y., Nasu, Y., Saigo, K., et al. (2008) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701118 · Cited by 110
Kelley, M. L., Keiger, K., Lee, C. J., & Huibregtse, J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3737-3747.2005 · Cited by 110
Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.037 · Cited by 100
Cherry, J. J., Rietz, A., Malinkevich, A., Liu, Y., Xie, M., Bartolowits, M. D., Davisson, V. J., Baleja, J., & Androphy, E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084506 · Cited by 97
Hellner, K., Mar, J., Fang, F., Quackenbush, J., & Münger, K. (2009) · Virology · doi:10.1016/j.virol.2009.05.036 · Cited by 94
Jabbar, S. F., Abrams, L., Glick, A. B., & Lambert, P. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0023 · Cited by 93
Wang, N., Zhan, T., Ke, T., Huang, X., Ke, D., Wang, Q., & Li, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.817 · Cited by 84
Xiong, Y., Kuppuswamy, D., Li, Y., Livanos, E., Hixon, M. L., White, A., Beach, D., & Tlsty, T. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.999-1008.1996 · Cited by 84
Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
D'Costa, Z. J., Jolly, C., Androphy, E. J., Mercer, A., Matthews, C. M., & Hibma, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048954 · Cited by 83
Effects of human papillomavirus type 16 oncoproteins on survivin gene expression
Borbély, Á., Murvai, M., Kónya, J., Beck, Z., Gergely, L., Li, F., & Veress, G. (2006) · Journal of General Virology · doi:10.1099/vir.0.81067-0 · Cited by 81
Neveu, G., Cassonnet, P., Vidalain, P., Rolloy, C., Mendoza, J., Jones, L. M., Tangy, F., Muller, M., Demeret, C., Tafforeau, L., et al. (2012) · Methods · doi:10.1016/j.ymeth.2012.07.029 · Cited by 79
Spangle, J. M., & Munger, K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003237 · Cited by 76
Yuan, C.-H., Filippova, M., & Duerksen-Hughes, P. J. (2012) · Viruses · doi:10.3390/v4123831 · Cited by 71
Aguilar‐Lemarroy, A., Gariglio, P., Whitaker, N. J., Eichhorst, S. T., Hausen, H. Z., Krammer, P. H., & Rösl, F. (2002) · Oncogene · doi:10.1038/sj.onc.1204979 · Cited by 66
Ding, W., Hu, Z., Zhu, D., Jiang, X., Yu, L., Wang, X., Zhang, C., Wang, L., Ji, T., Li, K., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0250 · Cited by 65
Nguyen, M. L., Song, S., Liem, A., Androphy, E. J., Liu, Y., & Lambert, P. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13039-13048.2002 · Cited by 65
Ghanbari, A., Gresley, A. L., Naughton, D. P., Kuhnert, N., Sirbu, D., & Ashrafi, G. H. (2019) · Scientific Reports · doi:10.1038/s41598-018-37665-6 · Cited by 63
Zhou, X., & Münger, K. (2009) · Virology · doi:10.1016/j.virol.2008.12.003 · Cited by 61
Rashid, N. N., Yusof, R., & Watson, R. J. (2011) · Journal of General Virology · doi:10.1099/vir.0.035352-0 · Cited by 55
Kim, M. S., Bak, Y., Park, Y. S., Lee, D. H., Kim, J. H., Kang, J. W., Song, H., Oh, S., & Yoon, D. Y. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9251-4 · Cited by 51
Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes
Liu, X., Disbrow, G. L., Yuan, H., Tomaić, V., & Schlegel, R. (2007) · Journal of Virology · doi:10.1128/jvi.00669-07 · Cited by 51
Immune alterations and immunotherapy prospects in head and neck cancer
Varilla, V., Atienza, J., & Dasanu, C. A. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.810716 · Cited by 49
Zhang, Y., Dakic, A., Chen, R., Dai, Y., Schlegel, R., & Liu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22036 · Cited by 48
TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells
Shankar, S., Prasad, D., Sanawar, R., Das, A. V., & Pillai, M. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-05696-0 · Cited by 44
Kwon, S.-B., Kim, M.-J., Yang, J. M., Lee, H.-P., Hong, J. T., Jeong, H., Kim, E. S., & Yoon, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150235 · Cited by 43
Tan, S., Hougardy, B. M. T., Meersma, G. J., Schaap, B., de Vries, E. G. E., van der Zee, A. G. J., & de Jong, S. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076539 · Cited by 39
Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
Shankar, S., Sreekumar, A., Prasad, D., Das, A. V., & Pillai, M. R. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0666-0 · Cited by 36
Eichten, A., Rud, D. S., Grace, M. R., Piboonniyom, S.-O., Zacny, V. L., & Münger, K. (2003) · Virology · doi:10.1016/j.virol.2003.11.008 · Cited by 33
Reschner, A., Bontems, S., Gac, S. L., Lambermont, J., Marcélis, L., Defrancq, É., Hubert, P., Moucheron, C., Mesmaeker, A. K., Raes, M. J., et al. (2012) · Gene Therapy · doi:10.1038/gt.2012.54 · Cited by 31
Deshpande, R., Raina, P., Shinde, K., Mansara, P., Karandikar, M., & Kaul-Ghanekar, R. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.04.002 · Cited by 31
Sun, K., Salmon, S. L., Yajjala, V. K., Bauer, C. D., & Metzger, D. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004560 · Cited by 28
E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes
Kim, Y., Cairns, M. J., Marouga, R., & Sun, L. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700623 · Cited by 24
Mino, T., Mori, T., Aoyama, Y., & Sera, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056633 · Cited by 23
Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21
Gao, P., Zhai, F., Guan, L., & Zheng, J. (2010) · Oncology Letters · doi:10.3892/ol.2010.205 · Cited by 21
The association of mammalian DREAM complex and HPV16 E7 proteins.
Rashid, N. N., Rothan, H. A., & Yusoff, M. S. M. (2015) · PubMed Central · Cited by 21
Mino, T., Aoyama, Y., & Sera, T. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.02.004 · Cited by 20
Zhou, X., Spangle, J. M., & Münger, K. (2009) · Autophagy · doi:10.4161/auto.5.4.8367 · Cited by 16
Togtema, M., Jackson, R., Grochowski, J., Villa, P. L., Mellerup, M., CHATTOPADHYAYA, J. B., & Zehbe, I. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0242 · Cited by 12
(1996) · PubMed
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Cervical cancer therapies: Current challenges and future perspectives
Burmeister, C. A., Khan, S. F., Schäfer, G., Mbatani, N., Adams, T., Moodley, J., & Prince, S. (2022) · Tumour Virus Research · doi:10.1016/j.tvr.2022.200238 · Cited by 474
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Shafer, P., Kelly, L. M., & Hoyos, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835762 · Cited by 270
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Tay, B. Q., Wright, Q., Ladwa, R., Perry, C., Leggatt, G., Simpson, F., Wells, J. W., Panizza, B. J., Frazer, I. H., & Cruz, J. L. G. (2021) · Vaccines · doi:10.3390/vaccines9050535 · Cited by 76
Metadata
- Authors
- Pal, A., & Kundu, R.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-01-21
- Volume
- 10
- Pages
- 3116-3116
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3001262658
- Cited by
- 597
- References
- 106
- FWCI
- 43.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.